Article
Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program.
Clinical pharmacology and therapeutics - 1 Aug 2008
Vossen C Y, Hoffmann M M, Hahmann H, Wüsten B, Rothenbacher D, Brenner H
Abstract excerpt
It has been suggested that the apolipoprotein E (APOE) genotype modifies the effect of dietary and pharmacological interventions for lowering lipid levels. We wanted to determine whether APOE genotyping information would be useful in making lipid-lowering treatment decisions in clinical practice. We included 981 patients with coronary heart disease (CHD) enrolled in an inpatient 3-week standardized rehabilitation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
